No Bad Blood-Surviving Severe Anemia Without Transfusion
Johnson-Arbor K, Verstraete R, JAMA Intern Med, 2021
Automatically imported from PubMed based on relevance criteria.
Summary not yet available for this study. View the original publication on PubMed.
Thanks for your feedback!
Study Details
| Study Type | Case Report |
| Category | Severe-anemia |
| Source | Pubmed |
| PubMed ID | 33226407 |
| Year Published | 2021 |
| Journal | JAMA Intern Med |
| MeSH Terms | Anemia; Bloodless Medical and Surgical Procedures; Female; Ferric Compounds; Hematinics; Humans; Hyperbaric Oxygenation; Infusions, Intravenous; Jehovah's Witnesses; Leiomyoma; Medroxyprogesterone; Middle Aged; Patient-Centered Care; Uterine Hemorrhage; Uterine Neoplasms |
Related Research
Tenth European Consensus Conference on Hyperbaric Medicine: recommendations for accepted and non-accepted clinical indications and practice of hyperbaric oxygen treatment.
Mathieu D, Marroni A, Kot J.
Effectiveness of hyperbaric oxygen therapy in the treatment of complex regional pain syndrome
Kiralp MZ, Yildiz S, Vural D, et al.
The effectiveness and safety of hyperbaric oxygen therapy in various phenotypes of inflammatory bowel disease: systematic review with meta-analysis
McCurdy J, Bhatt J, Engel-Yeger B, et al.
The efficacy of hyperbaric oxygen therapy in the management of chronic fatigue syndrome
Akarsu S, Tekin L, Ay H, et al.
Stem cell mobilization by hyperbaric oxygen
Thom SR, Bhopale VM, Velazquez OC, et al.
Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.